This Yield International ETF Combines Overseas Blue Chips And A Covered-Call Paycheck

American investors have a long, painful history of underweighting international stocks. The pitch for IDVO is that it solves two of those underweight excuses at once. The income from foreign blue chips already runs higher than the S&P 500’s, and a covered-call overlay turns that base yield into something closer to a monthly paycheck. IDVO’s recent run, where it has roughly doubled the return of the standard MSCI EAFE benchmark, is making the pitch harder to ignore.

The Amplify CWP International Enhanced Dividend Income ETF’s (NYSEARCA:IDVO) sub-advisor is Capital Wealth Planning, the same shop behind the better-known U.S.-focused Amplify CWP Enhanced Dividend Income ETF (NYSEARCA:DIVO). It charges 0.65% in expenses, and has gathered roughly $445 million in net assets. Its stated objective is current income first, capital appreciation second, benchmarked to the MSCI AC World Index Ex USA Net Index.

The job IDVO is hired to do

Think of IDVO as a one-ticker answer to the question, “how do I get paid to own Nestle, Novartis, and Toyota?” The portfolio is an active sleeve of high-quality ADRs from outside the U.S., and the manager writes covered calls tactically on individual names rather than blanketing the whole book. It pairs ADRs from outside the U.S. with a tactical covered call strategy on individual securities, which is a meaningful design choice.

Moreover, there’s a return engine with three parts. You collect dividends from the underlying ADRs, you pocket option premium on the names where the manager chooses to write calls, and you keep most of the capital appreciation on the names left uncalled. That tactical part matters. A fund like the Global X NASDAQ 100 Covered Call ETF (NASDAQ:QYLD) writes calls on the entire index every month and caps almost all upside in exchange for fat premium. IDVO is closer to a dividend portfolio with an income kicker than a yield-maxed options product.

Reading the scoreboard

Over the past year IDVO returned 38.69% on a total return basis, against 21.15% for the iShares MSCI EAFE ETF (NYSEARCA:EFA | EFA Price Prediction). Year-to-date, IDVO is up 11.61% versus 4.87% for EFA. Since inception in late 2022, the fund has roughly doubled, returning 107.95%.

Furthermore, the income side is doing real work too. 2026 monthly distributions have run between roughly $0.21, a clear step up from the $0.155 to $0.195 range investors saw across 2025. On a current share price near $42, that is real cash, and one Reddit dividend investor summarized the appeal of the CWP suite cleanly: “The call writing is selective and can allow more capital appreciation. The trade off is lower distributions.”

What you give up

Three honest tradeoffs sit underneath those numbers.

1. Capped upside on called names. Hence, even tactical covered calls clip the best months. In a sharp international rally, IDVO will lag a plain ADR basket, which is the cost of the premium income. Nonetheless, sharp international rallies are rare.
2. Cost and complexity versus alternatives. The 0.65% fee is roughly twice what you would pay for a passive international dividend index. Moreover, a portion of distributions can be classified as return of capital, which complicates tax reporting in a taxable account.
3. Manager and concentration risk. This is an actively managed ADR book that diverges from the MSCI EAFE. However, with 10-year Treasuries at 4.39%, the income story is competing with risk-free yield.

IDVO fits best as the international income sleeve for an investor who wants Nestle-and-Novartis exposure with a monthly check, and is comfortable trading a slice of upside in a melt-up rally for the smoother distribution stream that comes out the other side.